BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1231 related articles for article (PubMed ID: 19334039)

  • 21. A previously unidentified alternatively spliced isoform of t(8;21) transcript promotes leukemogenesis.
    Yan M; Kanbe E; Peterson LF; Boyapati A; Miao Y; Wang Y; Chen IM; Chen Z; Rowley JD; Willman CL; Zhang DE
    Nat Med; 2006 Aug; 12(8):945-9. PubMed ID: 16892037
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutations of the HIPK2 gene in acute myeloid leukemia and myelodysplastic syndrome impair AML1- and p53-mediated transcription.
    Li XL; Arai Y; Harada H; Shima Y; Yoshida H; Rokudai S; Aikawa Y; Kimura A; Kitabayashi I
    Oncogene; 2007 Nov; 26(51):7231-9. PubMed ID: 17533375
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LPXN, a member of the paxillin superfamily, is fused to RUNX1 in an acute myeloid leukemia patient with a t(11;21)(q12;q22) translocation.
    Dai HP; Xue YQ; Zhou JW; Li AP; Wu YF; Pan JL; Wang Y; Zhang J
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1027-36. PubMed ID: 19760607
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Molecular characterisation of a recurrent, semi-cryptic RUNX1 translocation t(7;21) in myelodysplastic syndrome and acute myeloid leukaemia.
    Foster N; Paulsson K; Sales M; Cunningham J; Groves M; O'Connor N; Begum S; Stubbs T; McMullan DJ; Griffiths M; Pratt N; Tauro S
    Br J Haematol; 2010 Mar; 148(6):938-43. PubMed ID: 20064152
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RUNX1/AML1 mutant collaborates with BMI1 overexpression in the development of human and murine myelodysplastic syndromes.
    Harada Y; Inoue D; Ding Y; Imagawa J; Doki N; Matsui H; Yahata T; Matsushita H; Ando K; Sashida G; Iwama A; Kitamura T; Harada H
    Blood; 2013 Apr; 121(17):3434-46. PubMed ID: 23471304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. AML1 deletion in adult mice causes splenomegaly and lymphomas.
    Putz G; Rosner A; Nuesslein I; Schmitz N; Buchholz F
    Oncogene; 2006 Feb; 25(6):929-39. PubMed ID: 16247465
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RUNX1 gene mutation in primary myelodysplastic syndrome--the mutation can be detected early at diagnosis or acquired during disease progression and is associated with poor outcome.
    Chen CY; Lin LI; Tang JL; Ko BS; Tsay W; Chou WC; Yao M; Wu SJ; Tseng MH; Tien HF
    Br J Haematol; 2007 Nov; 139(3):405-14. PubMed ID: 17910630
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Familial myelodysplasia and acute myeloid leukaemia--a review.
    Owen C; Barnett M; Fitzgibbon J
    Br J Haematol; 2008 Jan; 140(2):123-32. PubMed ID: 18173751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heterogeneous patterns of CEBPalpha mutation status in the progression of myelodysplastic syndrome and chronic myelomonocytic leukemia to acute myelogenous leukemia.
    Shih LY; Huang CF; Lin TL; Wu JH; Wang PN; Dunn P; Kuo MC; Tang TC
    Clin Cancer Res; 2005 Mar; 11(5):1821-6. PubMed ID: 15756005
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of the runt homology domain of RUNX1 disrupts homeostasis of hematopoietic stem cells and induces progression to myelodysplastic syndrome.
    Matsuura S; Komeno Y; Stevenson KE; Biggs JR; Lam K; Tang T; Lo MC; Cong X; Yan M; Neuberg DS; Zhang DE
    Blood; 2012 Nov; 120(19):4028-37. PubMed ID: 22919028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. BCL-2 and mutant NRAS interact physically and functionally in a mouse model of progressive myelodysplasia.
    Omidvar N; Kogan S; Beurlet S; le Pogam C; Janin A; West R; Noguera ME; Reboul M; Soulie A; Leboeuf C; Setterblad N; Felsher D; Lagasse E; Mohamedali A; Thomas NS; Fenaux P; Fontenay M; Pla M; Mufti GJ; Weissman I; Chomienne C; Padua RA
    Cancer Res; 2007 Dec; 67(24):11657-67. PubMed ID: 18089795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Activated leukemic oncogenes responsible for neoplastic transformation of hematopoietic cells].
    Baskaran D; Spirin PV; Prasolov VS
    Mol Biol (Mosk); 2010; 44(3):418-30. PubMed ID: 20608165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High incidence of somatic mutations in the AML1/RUNX1 gene in myelodysplastic syndrome and low blast percentage myeloid leukemia with myelodysplasia.
    Harada H; Harada Y; Niimi H; Kyo T; Kimura A; Inaba T
    Blood; 2004 Mar; 103(6):2316-24. PubMed ID: 14615365
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Defining the oncogenic function of the TEL/AML1 (ETV6/RUNX1) fusion protein in a mouse model.
    Fischer M; Schwieger M; Horn S; Niebuhr B; Ford A; Roscher S; Bergholz U; Greaves M; Löhler J; Stocking C
    Oncogene; 2005 Nov; 24(51):7579-91. PubMed ID: 16044150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Transcriptional dysregulation during myeloid transformation in AML.
    Pabst T; Mueller BU
    Oncogene; 2007 Oct; 26(47):6829-37. PubMed ID: 17934489
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Implications of somatic mutations in the AML1 gene in radiation-associated and therapy-related myelodysplastic syndrome/acute myeloid leukemia.
    Harada H; Harada Y; Tanaka H; Kimura A; Inaba T
    Blood; 2003 Jan; 101(2):673-80. PubMed ID: 12393679
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gatekeeper function of the RUNX1 transcription factor in acute leukemia.
    Niebuhr B; Fischer M; Täger M; Cammenga J; Stocking C
    Blood Cells Mol Dis; 2008; 40(2):211-8. PubMed ID: 17920312
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The leukemia-associated transcription repressor AML1/MDS1/EVI1 requires CtBP to induce abnormal growth and differentiation of murine hematopoietic cells.
    Senyuk V; Chakraborty S; Mikhail FM; Zhao R; Chi Y; Nucifora G
    Oncogene; 2002 May; 21(20):3232-40. PubMed ID: 12082639
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High frequency of AML1/RUNX1 point mutations in radiation-associated myelodysplastic syndrome around Semipalatinsk nuclear test site.
    Zharlyganova D; Harada H; Harada Y; Shinkarev S; Zhumadilov Z; Zhunusova A; Tchaizhunusova NJ; Apsalikov KN; Kemaikin V; Zhumadilov K; Kawano N; Kimura A; Hoshi M
    J Radiat Res; 2008 Sep; 49(5):549-55. PubMed ID: 18724045
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 62.